Company registration number 11149410 (England and Wales)
LONDON GYNAE CANCER LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2023
PAGES FOR FILING WITH REGISTRAR
LONDON GYNAE CANCER LIMITED
COMPANY INFORMATION
Director
Dr R Nath
Company number
11149410
Registered office
59 Alleyn Road
Dulwich
Middlesex
United Kingdom
SE21 8AD
Accountants
Koshal Associates (Chartered Accountants)
Gautam House
1-3 Shenley Avenue
Ruislip Manor
Middlesex
United Kingdom
HA4 6BP
LONDON GYNAE CANCER LIMITED
CONTENTS
Page
Balance sheet
2
Notes to the financial statements
3 - 4
LONDON GYNAE CANCER LIMITED
ACCOUNTANTS' REPORT TO THE DIRECTOR ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF LONDON GYNAE CANCER LIMITED FOR THE YEAR ENDED 31 JANUARY 2023
- 1 -

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of London Gynae Cancer Limited for the year ended 31 January 2023 which comprise, the balance sheet and the related notes from the company’s accounting records and from information and explanations you have given us.

It is your duty to ensure that London Gynae Cancer Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of London Gynae Cancer Limited. You consider that London Gynae Cancer Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of London Gynae Cancer Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Koshal Associates (Chartered Accountants)
13 October 2023
Gautam House
1-3 Shenley Avenue
Ruislip Manor
Middlesex
United Kingdom
HA4 6BP
LONDON GYNAE CANCER LIMITED
BALANCE SHEET
AS AT
31 JANUARY 2023
31 January 2023
- 2 -
2023
2022
Notes
£
£
£
£
Fixed assets
Investments
3
289,140
204,058
Current assets
Debtors
4
81,200
53,001
Cash at bank and in hand
63,919
61,072
145,119
114,073
Creditors: amounts falling due within one year
5
(68,100)
(65,492)
Net current assets
77,019
48,581
Total assets less current liabilities
366,159
252,639
Creditors: amounts falling due after more than one year
6
(21,276)
(24,854)
Net assets
344,883
227,785
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
344,783
227,685
Total equity
344,883
227,785

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 January 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 13 October 2023
Dr R Nath
Director
LONDON GYNAE CANCER LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2023
- 3 -
1
Accounting policies
Company information

London Gynae Cancer Limited is a private company limited by shares incorporated in England and Wales. The registered office is 59 Alleyn Road, Dulwich, Middlesex, United Kingdom, SE21 8AD.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

1.3
Fixed asset investments

Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

1.4
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2023
2022
Number
Number
Total
1
1
3
Fixed asset investments
2023
2022
£
£
Other investments other than loans
289,140
204,058
LONDON GYNAE CANCER LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2023
3
Fixed asset investments
(Continued)
- 4 -
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 February 2022
204,058
Additions
85,082
At 31 January 2023
289,140
Carrying amount
At 31 January 2023
289,140
At 31 January 2022
204,058
4
Debtors
2023
2022
Amounts falling due within one year:
£
£
Other debtors
81,200
53,001
5
Creditors: amounts falling due within one year
2023
2022
£
£
Bank loans
4,376
5,175
Corporation tax
61,324
55,877
Other creditors
2,400
4,440
68,100
65,492
6
Creditors: amounts falling due after more than one year
2023
2022
£
£
Bank loans and overdrafts
21,276
24,854
2023-01-312022-02-01false13 October 2023CCH SoftwareCCH Accounts Production 2023.200No description of principal activityDr R Nath111494102022-02-012023-01-3111149410bus:Director12022-02-012023-01-3111149410bus:RegisteredOffice2022-02-012023-01-31111494102023-01-31111494102022-01-3111149410core:CurrentFinancialInstrumentscore:WithinOneYear2023-01-3111149410core:CurrentFinancialInstrumentscore:WithinOneYear2022-01-3111149410core:Non-currentFinancialInstrumentscore:AfterOneYear2023-01-3111149410core:Non-currentFinancialInstrumentscore:AfterOneYear2022-01-3111149410core:CurrentFinancialInstruments2023-01-3111149410core:CurrentFinancialInstruments2022-01-3111149410core:ShareCapital2023-01-3111149410core:ShareCapital2022-01-3111149410core:RetainedEarningsAccumulatedLosses2023-01-3111149410core:RetainedEarningsAccumulatedLosses2022-01-31111494102021-02-012022-01-3111149410core:WithinOneYear2023-01-3111149410core:WithinOneYear2022-01-3111149410core:Non-currentFinancialInstruments2023-01-3111149410core:Non-currentFinancialInstruments2022-01-3111149410bus:PrivateLimitedCompanyLtd2022-02-012023-01-3111149410bus:SmallCompaniesRegimeForAccounts2022-02-012023-01-3111149410bus:FRS1022022-02-012023-01-3111149410bus:AuditExemptWithAccountantsReport2022-02-012023-01-3111149410bus:FullAccounts2022-02-012023-01-31xbrli:purexbrli:sharesiso4217:GBP